1 / 10

Meaningful Use for Reportable Lab Results

Meaningful Use for Reportable Lab Results. Processes & Procedures. Meaningful Use for Reportable Lab Results. Initial lab contact Complete New Supplier Enrollment Form DLFDOHReportableLabResultsInquiry@doh.state.fl.us Florida Administrative Code (FAC) rule 6 4 D- 3

xylia
Download Presentation

Meaningful Use for Reportable Lab Results

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Meaningful Use for Reportable Lab Results Processes & Procedures

  2. Meaningful Use for Reportable Lab Results • Initial lab contact • Complete New Supplier Enrollment Form • DLFDOHReportableLabResultsInquiry@doh.state.fl.us • Florida Administrative Code (FAC) rule 64D-3 • Submit to FDOH for review: lab tests, specimen & organism lists • Set up test feed • Establish transport protocol with FDOH • sFTP / PHIN-MS / VPN • Send HL7 2.5.1 test message • Send MQF error report • https://phinmqf.cdc.gov/

  3. Meaningful Use for Reportable Lab Results • Once errors identified by the MQF tool have been adequately resolved your facility will receive its attestation notice as represented by having your facilities name placed on FDOH’s Meaningful Use webpage. • http://www.doh.state.fl.us/Disease_ctrl/epi/topics/Meaningful_Use.htm • Stage 2 is expected to require production data

  4. Meaningful Use for Reportable Lab Results • Merlin -ELR Filter: Parameter Matching • Required • Sending Application & LOINC Test Code • Additional • Specimen Type/site • Coded with Exception (CWE) • SNOMED/Local result code • Organism codes/names • Local test keywords/phrases • Structured Numeric (SN) • Reference Range/abnormal flags

  5. Filtering into MERLIN (Bureau of Epidemiology Surveillance System) • ELR Filter Assigns • County Responsibility • Merlin Test Code • Based on test names, result descriptions • Test Result Grouping • Observation • Order • Message • Data of Interest (DOI) Flag • Based on Test, result, interpretation (CDC Case Reporting Requirements)

  6. Top 5 LOINC Mapping Issues 1. LOINC and Local disease name should have the disease/Condition • Example: • S/CO Ratio test • What disease/Condition does this test name represent? • Exception would be Microorganism (Culture) tests. These typically have the organism name (i.e. Shigellasonnei) in the results 2. Disease/Condition in LOINC name should match the Disease/Condition in the local test name • Example: • Loinc test code/name 7855-0 DENV1+2+3+4 RNA SerQl PCR; • Local test code/name 9540 Human Coronavirus NL63 • Can't tell which disease this result represents. 3. Specimen type listed in LOINC name should match the specimen type listed in SPM or OBR specimen fields

  7. Top 5 LOINC Mapping Issues 4. Don't rely on the Loinc Name to send specimen type information • The SPM 4 and OBR 15 fields allow for much more detail which the Public Health Agency may need. • Example: • LOINC 5671-LEAD BLD-mCnc is what we often get initially from most providers. • While this does indicate that the specimen type was BLOOD, we need to know the site of the blood draw in order to determine if we have a confirmed or suspect case. • Expect coding for Blood, Venous or Blood, Capillary in the Specimen fields. 5. Use LOINC Long name or short name as opposed to component name. Example: • Example: Loinc 60420-7 • Component name = Dengue virus 2 RNA • Short Name = DENV2 RNA Ser QI PCR • Long Name = Dengue virus 2 RNA [Presence] in Serum by Probe and target amplification method

  8. Current Status of ELR and MU • Number of Facilities sending ELR to FDOH • 143 Commercial Labs • 58 Hospitals • Number of Facilities meeting Stage 1 MU criteria • 31 Hospitals

  9. Meaningful Use for Reportable Lab Results • Useful Links: • Florida’s Laboratory Guidelines Packet, http://www.doh.state.fl.us/disease_ctrl/epi/surv/LaboratoryPacket.pdf • Rule 64D-3, http://www.doh.state.fl.us/Disease_ctrl/epi/topics/64D-3_11-08.pdf • List of reportable diseases, http://www.doh.state.fl.us/Disease_ctrl/epi/surv/reportable_diseases_08.pdf • Meaningful Use FAQs, http://www.ahca.myflorida.com/medicaid/ehr/frequently_asked_questions.shtml • Florida’s Meaningful Use Webpage, http://www.doh.state.fl.us/Disease_ctrl/epi/topics/Meaningful_Use.htm • Message Quality Framework (MQF) Tool, https://phinmqf.cdc.gov/

  10. Meaningful Use for Reportable Lab Results Thanks, Hunter Davis, MS Meaningful Use Coordinator Bureau of Epidemiology Florida Department of Health 4052 Bald Cypress Way Tallahassee, FL 32399-1720 Phone: 850-245-4444 x2434 Hunter_Davis@doh.state.fl.us Ray Sullivan, MS Surveillance Section Business Analyst Bureau of Epidemiology Florida Department of Health 4052 Bald Cypress Way Tallahassee, FL 32399-1720 Phone: 850-245-4444x2434

More Related